Ruesch Center Symposium Focuses on Early-Onset GI Cancer
November 22nd, 2023
Gastrointestinal Cancers
Currently Available Clinical Trials from Georgetown Lombardi
Use the link above to search for these suggested keywords:
– Gastrointestinal Cancer
– Bladder Cancer
– Colorectal Cancer
– Liver Cancer
– Pancreatic Cancer
– Rectal Cancer
– Renal/Kidney Cancer
More clinical trials are available on NIH’s national clinical trial database.
Ruesch Center for the Cure of Gastrointestinal Cancers
Appointments:
(202) 444-2223
Office: 202-444-0275
Fax: (202) 444-1229
rueschcenter@ georgetown.edu
John Marshall, MD
Director, Otto J. Ruesch Center for the Cure of Gastrointestinal Cancers; Physician Executive Director, MedStar Washington DC Integrated Hematology Oncology Division; Chief, Division of Hematology and Oncology, MedStar Georgetown University Hospital; Professor of Medicine and Oncology, Georgetown University School of Medicine; Chief Medical Officer, Georgetown Lombardi, MedStar Georgetown Cancer Institute
You will be redirected to our clinical partner, MedStar Health.
About the Cancer
Gastrointestinal (GI) cancers remain among the most fatal cancers. Advances in treatment have lagged well behind other disease priorities such as breast cancer because of a smaller pool of research funding and fewer survivors to carry the torch of advocacy.
The Otto J. Ruesch Center for the Cure of Gastrointestinal Cancers at Georgetown University’s Lombardi Comprehensive Cancer Center and MedStar Georgetown University Hospital focuses on national efforts on curing this deadly set of diseases. Combining expertise in molecular medicine, translational research, and a patient-centered philosophy, the Ruesch Center realizes the dream of individualized curative therapies through research, care, and advocacy.
From the National Cancer Institute at the National Institutes of Health, find current information and resources on gastrointestinal cancers, incidence and survival statistics, treatment options, causes and prevention, coping strategies, clinical trials and research.
Learn more about treatment options for the following gastrointestinal cancers available through our academic health system partner, MedStar Health (note: links go to the MedStar Health website):
- Anal cancer
- Appendix cancer
- Bile duct tumors
- Colon cancer
- Esophageal cancer
- Gallbladder cancer
- Gastrointestinal stromal tumors (GIST)
- Liver cancer
- Pancreatic cancer
- Rectal cancer
- Small intestine cancer
- Stomach cancer
What We Offer
Gastrointestinal cancers include: Anal Cancer, Colorectal (Colon) Cancer, Esophageal Cancer, Gallbladder Cancer, Gastrointestinal Carcinoid Tumors, Liver Cancer, Pancreatic Cancer, Small Intestine Cancer, Stomach (Gastric) Cancer.
- Ruesch Center for the Cure of Gastrointestinal Cancers
- Clinical Trials: Through our clinical partnership with MedStar Health, Georgetown Lombardi is pleased to offer you access to cutting-edge clinical trials.
- Patient and Family Resources
Our Research
The Ruesch Center for the Cure of Gastrointestinal Cancers
Dramatic improvements in molecular biology have led to a better understanding of what makes cancers “tick.” New anti-cancer agents are being developed at an unprecedented pace. New technologies allow us to measure the many variables quickly and accurately. Improvements in bioinformatics allow us to analyze the resulting data sets. These advances form the foundation of personalized medicine, the only way forward in the quest to cure cancer.
Georgetown Lombardi’s world-renowned research faculty are discovering cancer risk factors, designing effective prevention strategies, and learning how to detect cancers earlier. They are developing and testing the cancer treatments of tomorrow — targeted therapies that will improve both survival and quality of life. They are making progress toward the ultimate goal: to eradicate cancer.
Gastrointestinal Cancer Research News from Georgetown Lombardi
